Trial Profile
Clinical Trials Insight: 700031874
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Feb 2009
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Graft-versus-host disease; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 06 Dec 2008 Results presented at ASH 2008, according to 1134572.
- 24 Mar 2008 New trial record.